Application of bacteriophages as surrogates for mammalian viruses: A case for use in filter validation based on precedents and current practices in medical and environmental virology

PDA Journal of Pharmaceutical Science and Technology

Volumn 53, Issue 2, 1999, Pages 75-82

  Aranha Creado, Hazel ^a,b   Brandwein, Harvey ^a  

^a PALL CORPORATION   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; DISEASE MARKER; DRUG CONTAMINATION; DRUG SAFETY; FILTER; GEL PERMEATION CHROMATOGRAPHY; GOOD MANUFACTURING PRACTICE; NONHUMAN; PRACTICE GUIDELINE; VALIDATION PROCESS; VIROLOGY; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS PATHOGENESIS;

BACTERIOPHAGES; REPRODUCIBILITY OF RESULTS; ULTRAFILTRATION; VIRAL LOAD; VIROLOGY;

EID: 0033059158     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. H. Anazawa, I. E. Lee, and K. Sakai, "HIV removal efficiency of Pall Ultipor VF DV50 Virus Removal Filter," Pharm Tech Japan 13:951-955 (1997).
2. H. Aranha-Creado and A. Herczeg, "Demonstration of clearance of murine leukemia virus by a tangential flow membrane filtration system-Pall Filtron Omega™ 300 K VR," Scientific and Technical Report, STR-FIL (manuscript in preparation) Pall Ultrafine Filtration Co., East Hills, NY (1998).
3. H. Aranha-Creado, K. Oshima, S. Jafari, G. Howard, Jr., and H. Brandwein, "Virus retention by a hydrophilic triple-layer PVDF microporous membrane filter," PDA J. Pharm. Sci. Technol. 51:119-124 (1997).
4. H. Aranha-Creado, J. Peterson, and P. Y. Huang, "Clearance of Murine Leukemia Virus from monoclonal antibody solutions by a hydrophilic PVDF microporous membrane filter," Biologicals 26:167-172 (1998).
5. A. F. Bradburne, P. R. Ball, and A. J. Hunter, "Evaluation of virus removal efficiency of membrane gas filters," Proceedings of the International Congress: Advanced Technologies for Manufacturing of Aseptic and Terminally Sterilized Pharmaceuticals and Biopharmaceuticals, Basel. Switzerland (1992).
6. L. V. J. Brando, "Cell culture systems," In P. R. Murray (Editor in chief), E. J. Baron, M. A. Pfaller, F. C. Tenover, R. H. Yolken, Eds., Manual of Clinical Microbiology: Sixth edition, pp. 158-165, ASM Press, Washington, DC (1995).
7. P. L. Brown, "Protective clothing for health care workers: liquid proofness versus microbiological resistance," In J. P. McBriarty and N. W. Henry, Eds., Performance of Protective Clothing: Fourth volume, ASTM STP 1133, pp. 65-82, American Society for Testing and Materials, Philadelphia, PA, (1992).
8. R. Carey, W. Herman, B. Herman, B. Krop, and J. Casamento, "A laboratory evaluation of standard leakage tests for surgical and examination gloves," J. Clin. Engineering 14:133-143 (1989).
9. H. Chung and M. D. Sobsey, "Comparative survival of indicator viruses and enteric viruses in seawater and sediment," Wat. Sci. Tech. 27:425-428 (1993).
10. R. DeLeon, S. M. Matsui, R. S. Baric, J. E. Hermann, N. R. Blacklow, H. B. Greenberg, and M. D. Sobsey, "Detection of Norwalk virus in stool specimens by reverse transcriptase-polymerase chain reaction and nonradioactive oligoprobes, J. Clin. Microbiol. 30:3151-3157 (1992).
11. J. C. Desenclos, K. C. Klontz, M. H. Wilder, O. V. Naiman, H. S. Margolis, and R. A. Gunn, "A multistate outbreak of hepatitis A caused by the consumption of raw oysters," Am. J. Public Health 81:1268-1272 (1991).
12. A. J. DiLeo, D. A. Vacante, and E. Deane, "Size exclusion removal of model mammalian viruses using a unique membrane system, Part I: Membrane qualification," Biologicals 21:275-286 (1993).
13. G. A. Erickson, S. R. Bolin and J. G. Lundgraf, "Viral contamination of fetal bovine serum used for tissue culture: risks and concerns," Dev. Biol. Stand. 75:173-175 (1991).
14. J. P. Fox, C. Manso, H. A. Penna, and M. Pare, "Observation on the occurrence of icterus in Brazil following vaccination against yellow fever," Am. J. Hyg. 36:68-116 (1942).
15. R. Figueroa, A. Sopulveda, M. A. Soto, and J. Teha, "Informational analysis of MS2 and φX-174 virus genomes," J. Theor. biol. 74:203-207.
16. R. L. Garnick, "Experience with viral contamination in cell culture," Dev. Biol. Stand. 88:49-56 (1996).
17. C. P. Gerba, S. M. Goyal, R. L. LaBelle, I. Cech, and G. F. Bodgan, "Failure of indicator bacteria to reflect the occurrence of enteroviruses in marine waters," Am. J. Public Health 69:1116-1119 (1979).
18. W. O. K. Grahow, "Indicator systems for assessment of the virological safety of treated drinking water," Wat. Sci. Tech. 18:159-165 (1986).
19. W. O. K. Grabow and P. Coubrough, "A practical direct plaque assay for coliphages in 100 ml samples of drinking water," Appl. Environ. Microbiol. 52:430-433 (1986).
20. W. O. K. Grabow and M. Du Preez, "Comparison of m-Endo, LES, MacConkey, and Teepol media for membrane filtration counting of total coliform bacteria in water," Appl. Environ. Microbiol. 38:351-358 (1979).
21. W. O. K. Grabow, P. Coubrough, E. M. Nupen, and B. W. Bateman, "Evaluation of coliphages as indicators of the virological quality of sewage-polluted water," Wat. S. A. 10:7-14 (1984).
22. Guidelines for Sterile Drug Products Produced by Aseptic Processing, Center for Drugs and Biologies and Office of Regulatory Affairs, U. S., FDA, Washington, D. C., June 1987.
23. R. J. C. Harris, R. M. Dougherty, P. M. Biggs, L. N. Payne, A. P. Goffe, and A. E. Churchill, "Contaminant viruses in two live virus vaccines produced in chick cells," J. Hyg. (Cambridge) 64:1-6 (1966).
24. A. H. Havelaar, K. Furuse, and W. M. Hogeboom, "Bacteriophages and indicator bacteria in human and animal faeces," J. Appl. Bacteriol. 60:255-262 (1986).
25. A. H. Havelaar, W. M. Hogeboom, and R. Pot, "F specific RNA bacteriophages in sewage: methodology and occurrence," Wat. Sci. Tech. 17:645-655 (1984).
26. ICH harmonized tripartite guideline (1997) Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin, Step 4 Adoption Recommendation, pp. 1-27, IFPMA, Geneva, Switzerland.
27. X. Jiang, M. K. Estes, and T. G. Metcalf, "Detection of hepatitis A virus by hybridization with single-stranded RNA probes," Appl. Environ. Microbiol. 53:2487-2495 (1987).
28. J. Jofre, A. Bosch, F. Lucena, R. Girones, and C Tartera, "Evaluation of Bacteroides fragilis bacteriophages as indicators of the virological quality of water," Wat. Sci. Tech. 18:167-173 (1986).
29. J. Jofre, E. Olle, F. Ribas, A. Vidai, and F. Lucena, "Potential usefulness of bacteriophages that infect Bacteroides fragilis as model organisms for monitoring virus removal in drinking water treatment plants," Appl. Environ. Microbiol. 61:3227-3231 (1995).
30. M. V. K. Jones, K. Bellamy, R. Alcock, and R. Hudson, "The use of bacteriophage MS2 and a model system to evaluate virucidal hand disinfectants," J. Hosp. Inject. 17:279-285 (1991).
31. H. R. Kotilainen, W. H. Cyr, W. Truscott, N. M. Gantz, L. B. Routson, and C. D. Lytle, "Ability of 100 ml water leak tesl for medical gloves to detect gloves with potential for virus penetration," In J. P. McBriarty and N. W. Henry. Eds., Performance of Protective Clothing: Fourth volume, ASTM STP 1133, pp. 38-48, American Society for Testing and Materials, Philadelphia, PA, (1992).
32. Y. Kott, N. Roze, S. Sperber, and N. Betzer, "Bacteriophages as viral pollution indicators," Wat. Res. 8:165-171 (1974).
33. R. H. Lehman, and K. P. Bansemir, "The testing of disinfectants," Hyg. Med. 12:9-12 (1987).
34. F. Lucena, J. Lasobras, D. McIntosh, M. Forcadell, and J. Jofre, "Effect of distance from the polluting focus on relative concentrations of Bacteroides fragilis phages and coliphages in mussels," Appl. Environ. Microbiol. 60:2272-2277 (1994).
35. C. D. Lytle, P. G. Carney, S. Vohra, W. H. Cyr, and L. E. Bockstahler, "Virus leakage through natural membrane condoms," Sex. Transm. Dis. 17:58-62 (1990).
36. C. D. Lytle, A. P. Budacz, E. Keville, S. A. Miller, and K. N. Prodouz, "Differential Inactivation of Surrogate Viruses with Merocyanine 540," Photochemistry and Photobiol. 54:489-493 (1991).
37. C. D. Lytle, S. C. Tondreau, W. Truscott, A. P. Budacz, R. K. Kuester, L. Venegas, R. E. Schmukler, and W. H. Cyr, "Filtration Sizes of Human Immunodeficiency Virus Type 1 and Surrogate Viruses Used to Test Barrier Materials," Appl. Environ. Microbiol. 58:747-749 (1992).
38. C. D. Lytle, W. Truscott, A. P. Budacz, L. Venegas, L. B. Rouston, and W. H. Cyr, "Important Factors for Testing Barrier Materials with Surrogate Viruses," Appl. Environ. Microbiol. 57:2549-2554 (1991).
39. J. Y. Maillard, T. S. Beggs, M. J. Day, R. A. Hudson, and A. D. Russell, "Effect of biocides on MS2 and K coliphages," Appl. Environ. Microbiol. 60:2205-2206 (1994).
40. T. Meltzer, "Viable and non-viable particle and pyrogen retention," In T. Meltzer, Ed., Filtration in the Pharmaceutical Industry," pp. 493-544, Marcel Dekker Inc., N.Y. (1987).
41. R. H. Olsen, J. S. Siak, and R. H. Gray, "Characteristics of PRDI, a plasmid-dependent broad host range DNA bacteriophage," J. Virol. 14:689-699 (1974).
42. K. H. Oshima, T. T. Evans-Strickfaden, A. K. Highsmith, and E. W. Ades. "The removal of phage T1 and PP7, poliovirus from fluids with 50,000. 13,000, and 6,000 molecular weight, hollow fiber ultrafilters," Can. J. Microbiol. 41:316-322 (1995).
43. K. H. Oshima, T. T. Evans-Strickfaden, A. K. Highsmith, and E. W. Ades, "The use of a microporous polyvinylidene fluoride (PVDF) membrane filter to separate contaminating viral particles from biologically important proteins." BiologicalS 24:137-145 (1996).
44. D. B. Pall, "Quality control of absolute bacteria removal filters," Bull. PDA 29:192-204 (1975).
45. P. Payment, "Elimination of coliphages. Clostridium perfringens and human enteric viruses during drinking water treatment: Results of large volume sampling," War. Sci. Tech. 24:213-215 (1991).
46. H. Rabenau, V. Ohlinger, J. Anderson, B. Selb, J. Cinatl, W. Wolf, J. Frost, P. Mellor, and H. W. Doerr, "Contamination of genetically engineered CHO-cells by epizootic haemorrhagic disease virus (EHDV)," Biologicals 21:207-214 (1993).
47. P. Roberts, "Efficient removal of viruses by a novel polyvinylidene fluoride membrane filter," J. Virol. Methods 65:27-31 (1997).
48. K. Shah and N. Nathanson. "Human exposure to SV40: review and comment," Am. J. Epidemiol. 103:1-12 (1976).
49. R. E. Stetler, "Coliphages as indicators of Enteroviruses," Appl. Environ. Microbiol 48:668-670 (1984).
50. B. I. Truman, H. P. Madore, M. A. Menegus, J. L. Nitzkin, and R. Dolin, "Snow mountain agent gastroenteritis from clams," Am. J. Epidemiol. 126:516-525 (1987).
51. "Validation Guide for Pall Ultipor® VF™ Grade DV50 Ultipleat™ AB Style Virus Removal Filter Cartridges," Publication TR-UDV50, Pall Ultrafine Filtration Company, Pall Corporation, East Hills, N.Y. (1995).
52. A. K. Vidaver, R. K. Koski, and J. L. Van Etten, "Bacteriophage φ6: a lipid-conlaining virus of Pseudomonas phaseolicoli," J. Virol. 11:799-805 (1973).
53. B. Voeller, J. Nelson, and C. Day, "Viral leakage risk differences in latex condoms," AIDS Research and Human Retroviruses 10:701-710 (1994).